References
- 1. E. J. Benjamin, P. Muntner, A. Alonso, M. S. Bittencourt, C. W. Callaway, A. P. Carson, A. M. Chamberlain, A. R. Chang, S. Cheng, S. R. Das, F. N. Delling, L. Djousse, M. S. V. Elkind, J. F. Ferguson, M. Fornage, L. C. Jordan, S. S. Khan, B. M. Kissela, K. L. Knutson, T. W. Kwan, D. T. Lackland, T. T. Lewis, J. H. Lichtman, C. T. Longenecker, M. S. Loop, P. L. Lutsey, S. S. Martin, K. Matsushita, A. E. Moran, M. E. Mussolino, M. O’Flaherty, A. Pandey, A. M. Perak, W. D. Rosamond, G. A. Roth, U. K. A. Sampson, G. M. Satou, E. B. Schroeder, S. H. Shah, N. L. Spartano, A. Stokes, D. L. Tirschwell, C. W. Tsao, M. P. Turakhia, L. B. VanWagner, J. T. Wilkins, S. S. Wong and S. S. Virani, Heart disease and stroke statistics-2019 update: A report from the American Heart Association, Circulation139 (2019) e56–e528; https://doi.org/10.1161/cir.0000000000000659
- 2. M. J. Budoff, S. Achenbach, R. S. Blumenthal, J. J. Carr, J. G. Goldin, P. Greenland, A. D. Guerci, J. A. Lima, D. J. Rader, G. D. Rubin, L. J. Shaw and S. E. Wiegers, Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology, Circulation114 (2006) 1761–1791; https://doi.org/10.1161/circulationaha.106.178458
- 3. P. Greenland, J. S. Alpert, G. A. Beller, E. J. Benjamin, M. J. Budoff, Z. A. Fayad, E. Foster, M. A. Hlatky, J. M. Hodgson, F. G. Kushner, M. S. Lauer, L. J. Shaw, S. C. Smith, A. J. Taylor, W. S. Weintraub and N. K. Wenger, 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation122 (2010) e584–e636; https://doi.org/10.1161/cir.0b013e3182051b4c
- 4. D. L. Bhatt, Can clopidogrel and aspirin lower mortality in patients with acute myocardial infarction? Nat. Clin. Pract. Cardiovasc. Med.3 (2006) 182–183; https://doi.org/10.1038/ncpcardio0508
- 5. J. Sullivan and N. Amarshi, Dual antiplatelet therapy with clopidogrel and aspirin, Am. J. Health Syst. Pharm.65 (2008) 1134–1143; https://doi.org/10.2146/ajhp060662
- 6. A. Algra and J. van Gijn, Is clopidogrel superior to aspirin in secondary prevention of vascular disease? Curr. Control Trials Cardiovasc. Med.1 (2000) 143–145; https://doi.org/10.1186/cvm-1-3-143
- 7. A. Grzybowski and K. Pietrzak, Albert Szent-Györgyi (1893-1986): the scientist who discovered vitamin C, Clin. Dermatol.31 (2013) 327–331; https://doi.org/10.1016/j.clindermatol.2012.08.001
- 8. B. Havsteen, Flavonoids, a class of natural products of high pharmacological potency, Biochem. Pharmacol.32 (1983) 1141–1148; https://doi.org/10.1016/S0163-7258(02)00298-X
- 9. K. Janssen, R. P. Mensink, F. J. Cox, J. L. Harryvan, R. Hovenier, P. C. Hollman and M. B. Katan, Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study, Am. J. Clin. Nutr.67 (1998) 255–262; https://doi.org/10.1093/ajcn/67.2.255
- 10. U. T. Seyfert, H. Haubelt, A. Vogt and P. Hellstern, Variables influencing Multiplate whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals, Platelets18 (2007) 199–206. https://doi.org/10.1080/09537100600944277
- 11. M. Bojić, Ž. Debeljak, M. Medić-Šarić and M. Tomičić, Interference of selected flavonoid aglycons in platelet aggregation assay, Clin. Chem. Lab. Med.50 (2012) 1403–1408; https://doi.org/10.1515/cclm-2011-0960
- 12. M. Bojić, Ž. Debeljak, M. Tomičić, M. Medić-Šarić and S. Tomić, Evaluation of antiaggregatory activity of flavonoid aglycone series, Nutr. J.10 (2011) Article ID 73 (8 pages); https://doi.org/10.1186/1475-2891-10-73
- 13. A. Calatzis, R. M. Loreth and M. Spannagl, Multiplate®Platelet Function Analysis – Application and Interpretation, Dynabyte GmbH, Munich 2006.
- 14. M. Bijak, A. Sut, A. Kosiorek, J. Saluk-Bijak and J. Golanski J, Dual anticoagulant/antiplatelet activity of polyphenolic grape seeds extract, Nutrients11 (2019) Article ID 93 (9 pages); https://doi.org/10.3390/nu11010093
- 15. A. Meshkini and M. Tahmasbi, Antiplatelet aggregation activity of walnut hull extract via suppression of reactive oxygen species generation and caspase activation, J. Acupunct. Meridian Stud.10 (2017) 193–203; https://doi.org/10.1016/j.jams.2017.02.007
- 16. E. K. Yoon, S. K. Ku, W. Lee, S. Kwak, H. Kang, B. Jung and S. Bae, Antitcoagulant and antiplatelet activities of scolymoside, BMB Rep.48 (2015) 577–582; https://doi.org/10.5483/BMBRep.2015.48.10.044
- 17. S. K. Ku and J. S. Bae, Antithrombotic activities of wogonin and wogonoside via inhibiting platelet aggregation, Fitoterapia98 (2014) 27–35; https://doi.org/10.1016/j.fitote.2014.07.006
- 18. W. Lee W and J. S. Bae, Antithrombotic and antiplatelet activities of vicenin-2, Blood Coagul. Fibrinolysis26 (2015) 628–634; https://doi.org/10.1097/MBC.0000000000000320
- 19. A. Saija, M. Scalese, M. Lanza, D. Marzullo, F. Bonina and F. Castelli, Flavonoids as antioxidant agents: importance of their interaction with biomembranes, Free Radic. Biol. Med.19 (1995) 481‒486; https://doi.org/10.1016/0891-5849(94)00240-K
- 20. A. Polette, D. Lemaitre, M. Lagarde and E. Véricel, n-3 fatty acid-induced lipid peroxidation in human platelets is prevented by catechins, Thromb. Haemost.75 (1996) 945‒949; https://doi.org/10.1055/s-0038-1650399
- 21. T. J. Neiva, L. Morais, M. Polack, C. M. Simões and E. A. D’Amico, Effects of catechins on human blood platelet aggregation and lipid peroxidation, Phytother. Res.13 (1999) 597‒600; https://doi.org/10.1002/(SICI)1099-1573(199911)13:7<597::AID-PTR512>3.0.CO;2-Z
- 22. S. L. Hwang and G. C. Yen, Modulation of Akt, JNK, and p38 activation is involved in citrus flavonoid-mediated cytoprotection of PC12 cells challenged by hydrogen peroxide, J. Agric. Food. Chem.57 (2009) 2576‒2582; https://doi.org/10.1021/jf8033607
- 23. F. Orallo, E. Alvarez, H. Basaran and C. Lugnier, Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin, Naunyn. Schmiedebergs Arch. Pharmacol.370 (2004) 452‒463; https://doi.org/10.1007/s00210-004-0994-6
- 24. T. P. Dew, A. J. Day and M. R. Morgan, Xanthine oxidase activity in vitro: effects of food extracts and components, J. Agric. Food Chem.53 (2005) 6510‒6515; https://doi.org/10.1021/jf050716j
- 25. D. S. Chou, J. J. Lee, G. Hsiao, C. Y. Hsieh, Y. J. Tsai, T. F. Chen and J. R. Sheu, Baicalein induction of hydroxyl radical formation via 12-lipoxygenase in human platelets: an ESR study, J. Agric. Food Chem.55 (2007) 649‒655; https://doi.org/10.1021/jf062584f
- 26. Y. R. Jin, X. H. Han, Y. H. Zhang, J. J. Lee, Y. Lim, J. H. Chung and Y. P. Yun, Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity, Atherosclerosis194 (2007) 144‒152; https://doi.org/10.1016/j.atherosclerosis.2006.10.011
- 27. O. A. Ogunbayo, R. M. Harris, R. H. Waring, C. J. Kirk and F. Michelangeli, Inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by flavonoids: a quantitative structure-activity relationship study, IUBMB Life60 (2008) 853‒858; https://doi.org/10.1002/iub.132
- 28. G. P. Hubbard, S. Wolffram, J. A. Lovegrove and J. M. Gibbins, Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans, J. Thromb. Haemost.2 (2004) 2138‒2145. https://doi.org/10.1111/j.1538-7836.2004.01067.x
- 29. B. Wright, L. A. Moraes, C. F. Kemp, W. Mullen, A. Crozier, J. A. Lovegrove and J. M. Gibbins, A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids, Br. J. Pharmacol.159 (2010) 1312‒1325; https://doi.org/10.1111/j.1476-5381.2009.00632.x
- 30. L. Liu, D. M. Xu and Y. Y. Cheng, Distinct effects of naringenin and hesperetin on nitric oxide production from endothelial cells, J. Agric. Food Chem.56 (2008) 824‒829; https://doi.org/10.1021/jf0723007
- 31. M. Dell’Agli, O. Maschi, G. V. Galli, R. Fagnani, E. Dal Cero, D. Caruso and E. Bosisio, Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase, Br. J. Nutr.99 (2008) 945‒951; https://doi.org/10.1017/S0007114507837470
- 32. J. H. Lee and G. H. Kim, Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis, J. Food Sci.75 (2010) H212‒H217; https://doi.org/10.1111/j.1750-3841.2010.01755.x
- 33. J. Vibes, B. Lasserre, J. Gleye and C. Declume, Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxyacantha (Hawthorn) flower heads, Prostaglandins Leukot. Essent. Fatty Acids50 (1994) 173‒175; https://doi.org/10.1016/0952-3278(94)90141-4
- 34. I. Babić, M. Bojić, Ž. Maleš, R. Zadro, K. Gojčeta, I. Duka, H. Rimac and I. Jukić, Influence of flavonoids’ lipophilicity on platelet aggregation, Acta Pharm. 69 (2019) (this issue).
- 35. M. L. Liang, X. W. Da, A. D. He, G. Q. Yao, W. Xie, G. Liu, J. Z. Xiang and Z. Y. Ming, Pentamethylquercetin (PMQ) reduces thrombus formation by inhibiting platelet function, Sci. Rep.5 (2015) 11142 (11 pages); https://doi.org/10.1038/srep11142
- 36. Ž. Maleš, A. Antolić, I. Babić, S. Jurić and M. Bojić, Quantitative analysis of phenolic acids and anti-platelet activity of Melissa officinalis leaf extracts, Nat. Prod. Commun.12 (2017) 93–94; https://doi.org/10.1177/1934578X1701200126
- 37. O. Estrada, W. Contreras, G. Acha, E. Lucena, W. Venturini, A. Cardozo and C. Alvarado-Castillo, Chemical constituents from Licania cruegeriana and their cardiovascular and antiplatelet effects, Molecules19 (2014) 21215–21225; https://doi.org/10.3390/molecules191221215
- 38. R. Kasimu, Z. Fan, X. Wang, J. Hu, P. Wang and J. Wang, Anti-platelet aggregation activities of different fractions in leaves of Apocynum venetum L., J. Ethnopharmacol.168 (2015) 116–121; https://doi.org/10.1016/j.jep.2015.03.0130378-8741
- 39. J. Y. Ro, J. H. Ryu, H. J. Park and H. J. Cho, Onion (Allium cepa L.) peel extract has anti-platelet effects in rat platelets, Springerplus4 (2015) 17 (8 pages); https://doi.org/10.1186/s40064-015-0786-0
- 40. A. Antolić, Ž. Maleš, M. Tomičić and M. Bojić, The effect of short-toothed and Dalmatian sage extracts on platelet aggregation, Food Technol. Biotech.56 (2018) 265–269; https://doi.org/10.17113/ftb.56.02.18.5474
- 41. A. D. Assefa, E. Y. Ko, S. H. Moon and Y. S. Keum, Antioxidant and antiplatelet activities of flavonoid-rich fractions of three citrus fruits from Korea, 3 Biotech. 6 (2016) 109 (10 pages); https://doi.org/10.1007/s13205-016-0424-8
- 42. M. Bojić, A. Antolić, M. Tomičić, Ž. Debeljak and Ž. Maleš, Propolis ethanolic extracts reduce adenosine diphosphate induced platelet aggregation determined on whole blood, Nutr. J.17 (2018) 52 (8 pages); https://doi.org/10.1186/s12937-018-0361-y
- 43. C. H. Lescano, F. Freitas de Lima, C. B. Mendes-Silvério, A. F. O. Justo, D. da Silva Baldivia, C. P. Vieira, E. J. Sanjinez-Argandoña, C. A. L. Cardoso, F. Z. Mónica and I. Pires de Oliveira, Effect of polyphenols from Campomanesia adamantium on platelet aggregation and inhibition of cyclooxygenases: Molecular docking and in vitro analysis, Front. Pharmacol.9 (2018) 617 (13 pages); https://doi.org/10.3389/fphar.2018.00617
- 44. A. Mira, W. Alkhiary and K. Shimizu, Antiplatelet and anticoagulant activities of Angelica shikokiana extract and its isolated compounds, Clin. Appl. Thromb. Hemost.23 (2017) 91–99; https://doi.org/10.1177/1076029615595879
- 45. A. A. Boligon, V. C. Pimentel, M. D. Bagatini and M. L. Athayde, Effect of Scutia buxifolia Reissek in nucleotidase activities and inhibition of platelet aggregation, J. Nat. Med.69 (2015) 46–54; https://doi.org/10.1007/s11418-014-0858-4
- 46. S. U. Kwon, H. Y. Lee, M. Xin, S. J. Ji, H. K. Cho, D. S. Kim, D. K. Kim and Y. M. Lee, Antithrombotic activity of Vitis labrusca extract on rat platelet aggregation, Blood Coagul. Fibrin.27 (2016) 141–146; https://doi.org/10.1097/MBC.0000000000000394
- 47. M. S. Rajput, N. Balekar and D. K. Jain, Inhibition of ADP-induced platelet aggregation and involvement of non-cellular blood chemical mediators are responsible for the antithrombotic potential of the fruits of Lagenaria siceraria, Chin. J. Nat. Med.12 (2014) 599–606; https://doi.org/10.1016/S1875-5364(14)60091-1
- 48. J. Rywaniak, B. Luzak, A. Podsedek, D. Dudzinska, M. Rozalski and C. Watala, Comparison of cytotoxic and anti-platelet activities of polyphenolic extracts from Arnica montana flowers and Juglans regia husks, Platelets26 (2015) 168–176; https://doi.org/10.3109/09537104.2014.894970
- 49. R. Zamora-Ros, V. Knaze, L. Luján-Barroso, N. Slimani, I. Romieu, V. Fedirko, M. S. Magistris, U. Ericson, P. Amiano, A. Trichopoulou, V. Dilis, A. Naska, D. Engeset, G. Skeie, A. Cassidy, K. Overvad, P. H. M. Peeters, J. M. Huerta, M.-J. Sánchez, J. R. Quirós, C. Sacerdote, S. Grioni, R. Tumino, G. Johansson, I. Johansson, I. Drake, F. L. Crowe, A. Barricarte, R. Kaaks, B. Teucher, H. B. Bueno-de-Mesquita, C. T. M. Rossum, T. Norat, D. Romaguera, A.-C. Vergnaud, A. Tjønneland, J. Halkjær, F. Clavel-Chapelon, M.-C. Boutron-Ruault, M. Touillaud, S. Salvini, K.-T. Khaw, N. Wareham, H. Boeing, J. Förster, E. Riboli and C. A. González, Estimated dietary intakes of flavonols, flavanones and flavones in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24 hour dietary recall cohort, Br. J. Nutr.106 (2011) 1915–1925; https://doi.org/10.1017/S000711451100239X
- 50. P. C. Hollman, J. H. de Vries, S. D. van Leeuwen, M. J. Mengelers and M. B. Katan, Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers, Am. J. Clin. Nutr.62 (1995) 1276‒1282; https://doi.org/10.1093/ajcn/62.6.1276
- 51. C. Manach, G. Williamson, C. Morand, A. Scalbert and C. Rémésy, Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies, Am. J. Clin. Nutr.81 (2005) 230S–242S; https://doi.org/10.1093/ajcn/81.1.230S
- 52. K. S. Krogholm, L. Bredsdorff, P. Knuthsen, J. Haraldsdóttir and S. E. Rasmussen, Relative bioavailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet, Eur. J. Clin. Nutr.64 (2010) 432–435; http://doi.org/10.1038/ejcn.2010.6
- 53. I. Palomo, A. Concha-Meyer, M. Lutz, M. Said, B. Sáez, A. Vásquez and E. Fuentes, Chemical characterization and antiplatelet potential of bioactive extract from tomato pomace (byproduct of tomato paste), Nutrients11 (2019) Article ID 456 (10 pages); https://doi.org/10.3390/nu11020456
- 54. T. Nickel, K. Lackermair, J. Scherr, A. Calatzis, M. Vogeser, H. Hanssen, G. Waidhauser, U. Schönermark, H. Methe, S. Horster, U. Wilbert-Lampen and M. Halle, Influence of high polyphenol beverage on stress-induced platelet activation, J. Nutr. Health Aging20 (2016) 586–593; https://doi.org/10.1007/s12603-016-0697-y
- 55. K. Thompson, H. Hosking, W. Pederick, I. Singh and A. B. Santhakumar, The effect of anthocyanin supplementation in modulating platelet function in sedentary population: a randomised, double-blind, placebo-controlled, cross-over trial, Br. J. Nutr.118 (2017) 368–374; https://doi.org/10.1017/S0007114517002124
- 56. J. J. Peterson, J. T. Dwyer, P. F. Jacques and M. L. McCullough, Do flavonoids reduce cardiovascular disease incidence or mortality in US and European populations? Nutr. Rev.70 (2012) 491–508; https://doi.org/10.1111/j.1753-4887.2012.00508.x
- 57. Z. M. Wang, D. Zhao, Z. L. Nie, H. Zhao, B. Zhou, W. Gao, L. S. Wang and Z. J. Yang, Flavonol intake and stroke risk: a meta-analysis of cohort studies, Nutrition30 (2014) 518–523; https://doi.org/10.1016/j.nut.2013.10.009